Robert Nelsen, Director of Kardigan KARD, has filed 32 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $57.3M. The latest trade was on 06/22.

Robert Nelsen

Director

Company: Kardigan KARD
First filing: 23/01/06

Trades: 96 trades
Buys / sales: 32 / 0
12-month net buying: $57.3M
Last trade: 06/22

Trading activity

Transactions

	Trade type
KardiganKARD	Open-market buy	06/22	06/24	1,250,000 sh	$16.00	$20,000,000	+9.1%
Seaport TherapeuticsSPTX	Open-market buy	05/04	05/04	1,100,000 sh	$18.00	$19,800,000	+21.2%
Lyell ImmunopharmaLYEL	Open-market buy	03/06	03/09	488,090 sh	$25.61	$12,499,984.9	+52.0%
Neumora TherapeuticsNMRA	Open-market buy	25/10/27	25/10/29	1,915,700 sh	$2.61	$4,999,977	+46.4%
Prime MedicinePRME	Open-market buy	25/08/01	25/08/01	3,030,300 sh	$3.30	$9,999,990	+94.7%
	Open-market buy	25/02/03	25/02/03	2,222,222 sh2 trades	$18.00avg.	$39,999,996	+36.5%
BOLD	Open-market buy	24/04/02	24/04/04	200,000 sh2 trades	$16.00avg.	$3,200,000	+20.4%
Prime MedicinePRME	Open-market buy	24/02/15	24/02/20	3,200,000 sh	$6.25	$20,000,000	No record
SANA	Open-market buy	24/02/08	24/02/12	1,818,181 sh3 trades	$5.50avg.	$9,999,995.5	+17.1%
NMRA	Open-market buy	23/11/13–23/11/14	23/11/15	35,010 sh2 trades	$11.77avg.	$412,139.61	+0.9%
NMRA	Open-market buy	23/11/08–23/11/10	23/11/13	140,605 sh5 trades	$10.98avg.	$1,543,563.42	+3.6%
NMRA	Open-market buy	23/11/03–23/11/07	23/11/07	95,694 sh3 trades	$11.49avg.	$1,099,944.7	+2.5%
NMRA	Open-market buy	23/09/28–23/09/29	23/09/29	76,511 sh3 trades	$13.68avg.	$1,046,848.16	+2.0%
NMRA	Open-market buy	23/09/26–23/09/27	23/09/27	58,504 sh2 trades	$11.97avg.	$700,464.24	+1.6%
NMRA	Open-market buy	23/09/22–23/09/25	23/09/25	100,740 sh3 trades	$11.19avg.	$1,127,063.95	+2.8%
Neumora TherapeuticsNMRA	Open-market buy	23/09/19	23/09/20	1,500,000 sh	$17.00	$25,500,000	+70.6%